Constantinos Koumenis - Publications

Affiliations: 
Wake Forest University, Winston-Salem, NC, United States 
Area:
Cell Biology, Oncology, Virology Biology

123 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Perales-Linares R, Leli NM, Mohei H, Beghi S, Rivera OD, Kostopoulos N, Giglio A, George SS, Uribe-Herranz M, Costabile F, Pierini S, Pustylnikov S, Skoufos G, Barash Y, Hatzigeorgiou AG, ... Koumenis C, et al. Parkin deficiency suppresses antigen presentation to promote tumor immune evasion and immunotherapy resistance. Cancer Research. PMID 37578274 DOI: 10.1158/0008-5472.CAN-22-2499  0.324
2022 Roby KC, Lieberman A, Kim BJ, Rodríguez NZ, Posimo JM, Tsang T, Verginadis II, Puré E, Brady DC, Koumenis C, Ryeom S. Loss of p19Arf Promotes Fibroblast Survival During Leucine Deprivation. Biology Open. PMID 34994382 DOI: 10.1242/bio.058728  0.339
2020 Chao HH, Karagounis IV, Thomas C, François NB, Facciabene A, Koumenis C, Maity A. Combination of CHEK1/2 inhibition and ionizing radiation results in abscopal tumor response through increased micronuclei formation. Oncogene. PMID 32335582 DOI: 10.1038/S41388-020-1300-X  0.456
2020 Huang M, Zhang D, Wu JY, Xing K, Yeo E, Li C, Zhang L, Holland E, Yao L, Qin L, Binder ZA, O'Rourke DM, Brem S, Koumenis C, Gong Y, et al. Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. Science Translational Medicine. 12. PMID 32102932 DOI: 10.1126/Scitranslmed.Aay7522  0.397
2020 Thomas C, Karagounis I, Srivastava R, Kumar S, Francois N, Nikolos F, Bado I, Chao H, Koumenis C, Krishnamurthy S, Ueno NT, Chakrabarti R, Maity A. Abstract PD7-02: Estrogen receptor β suppresses metastasis of inflammatory breast cancer by regulating signaling that promotes cytoskeleton remodeling Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Pd7-02  0.411
2020 Karagounis IV, Pierini S, François N, Thomas C, Xu X, Koumenis C, Facciabene A, Maity A. Abstract 6509: Hypofractionated radiotherapy as a vaccine in combination with the TLR7/8 agonist resiquimod leads to significant abscopal tumor response and persistence antitumor immunity Cancer Research. 80: 6509-6509. DOI: 10.1158/1538-7445.Am2020-6509  0.405
2019 Bhardwaj M, Leli NM, Koumenis C, Amaravadi RK. Regulation of autophagy by canonical and non-canonical ER stress responses. Seminars in Cancer Biology. PMID 31838023 DOI: 10.1016/J.Semcancer.2019.11.007  0.421
2019 Uribe-Herranz M, Rafail S, Beghi S, Gil-de-Gómez L, Verginadis I, Bittinger K, Pustylnikov S, Pierini S, Perales-Linares R, Blair IA, Mesaros CA, Snyder NW, Bushman F, Koumenis C, Facciabene A. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response. The Journal of Clinical Investigation. PMID 31815742 DOI: 10.1172/Jci124332  0.356
2019 Tameire F, Verginadis II, Leli NM, Polte C, Conn CS, Ojha R, Salas Salinas C, Chinga F, Monroy AM, Fu W, Wang P, Kossenkov A, Ye J, Amaravadi RK, Ignatova Z, ... ... Koumenis C, et al. ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression. Nature Cell Biology. 21: 889-899. PMID 31263264 DOI: 10.1038/S41556-019-0347-9  0.428
2019 Gui J, Katlinski KV, Koumenis C, Diehl JA, Fuchs SY. The PKR-like endoplasmic reticulum kinase promotes the dissemination of Myc-induced leukemic cells. Molecular Cancer Research : McR. PMID 30902831 DOI: 10.1158/1541-7786.Mcr-19-0002  0.413
2019 Ortiz A, Gui J, Zahedi F, Yu P, Cho C, Bhattacharya S, Carbone CJ, Yu Q, Katlinski KV, Katlinskaya YV, Handa S, Haas V, Volk SW, Brice AK, Wals K, ... ... Koumenis C, et al. An Interferon-Driven Oxysterol-Based Defense against Tumor-Derived Extracellular Vesicles. Cancer Cell. 35: 33-45.e6. PMID 30645975 DOI: 10.1016/J.Ccell.2018.12.001  0.37
2019 Chatterjee S, Pietrofesa RA, Park K, Tao JQ, Carabe-Fernandez A, Berman AT, Koumenis C, Sielecki T, Christofidou-Solomidou M. LGM2605 Reduces Space Radiation-Induced NLRP3 Inflammasome Activation and Damage in In Vitro Lung Vascular Networks. International Journal of Molecular Sciences. 20. PMID 30621290 DOI: 10.3390/Ijms20010176  0.316
2019 Karagounis IV, Chao H, Tomas C, Koumenis C, Maity A. Abstract LB-116: Combination of a cell cycle checkpoint kinase inhibitor and ionizing radiation leads to abscopal tumor response through increased CD8+ infiltration Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-Lb-116  0.384
2018 Ojha R, Leli NM, Onorati A, Piao S, Verginadis II, Tameire F, Rebecca VW, Chude CI, Murugan S, Fennelly C, Noguera-Ortega E, Liu S, Xu X, Krepler C, Xiao M, ... ... Koumenis C, et al. ER translocation of the MAPK pathway drives therapy resistance in BRAF mutant melanoma. Cancer Discovery. PMID 30563872 DOI: 10.1158/2159-8290.Cd-18-0348  0.407
2018 Rivera-Reyes A, Ye S, E Marino G, Egolf S, E Ciotti G, Chor S, Liu Y, Posimo JM, Park PMC, Pak K, Babichev Y, Sostre-Colón J, Tameire F, Leli NM, Koumenis C, et al. YAP1 enhances NF-κB-dependent and independent effects on clock-mediated unfolded protein responses and autophagy in sarcoma. Cell Death & Disease. 9: 1108. PMID 30382078 DOI: 10.1038/S41419-018-1142-4  0.363
2018 Bi Y, Verginadis II, Dey S, Lin L, Guo L, Zheng Y, Koumenis C. Radiosensitization by the PARP inhibitor olaparib in BRCA1-proficient and deficient high-grade serous ovarian carcinomas. Gynecologic Oncology. PMID 30025822 DOI: 10.1016/J.Ygyno.2018.07.002  0.317
2018 Leli NM, Koumenis C. Pro-tumorigenic AMPK in glioblastoma Nature Cell Biology. 20: 736-737. PMID 29915356 DOI: 10.1038/S41556-018-0129-9  0.348
2018 Walton ZE, Patel CH, Brooks RC, Yu Y, Ibrahim-Hashim A, Riddle M, Porcu A, Jiang T, Ecker BL, Tameire F, Koumenis C, Weeraratna AT, Welsh DK, Gillies R, Alwine JC, et al. Acid Suspends the Circadian Clock in Hypoxia through Inhibition of mTOR. Cell. PMID 29861175 DOI: 10.1016/J.Cell.2018.05.009  0.397
2018 Nguyen HG, Conn CS, Kye Y, Xue L, Forester CM, Cowan JE, Hsieh AC, Cunningham JT, Truillet C, Tameire F, Evans MJ, Evans CP, Yang JC, Hann B, Koumenis C, et al. Development of a stress response therapy targeting aggressive prostate cancer. Science Translational Medicine. 10. PMID 29720449 DOI: 10.1126/Scitranslmed.Aar2036  0.441
2018 Yang Z, Zhang J, Jiang D, Khatri P, Solow-Cordero DE, Toesca DAS, Koumenis C, Denko NC, Giaccia AJ, Le QT, Koong AC. A Human Genome-wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1α-XBP1 Activation. Molecular Cancer Research : McR. PMID 29440447 DOI: 10.1158/1541-7786.Mcr-17-0307  0.384
2018 Wang Y, Xu H, Liu T, Huang M, Butter PP, Li C, Zhang L, Kao GD, Gong Y, Maity A, Koumenis C, Fan Y. Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells. Jci Insight. 3. PMID 29415883 DOI: 10.1172/Jci.Insight.98096  0.318
2017 Bu Y, Yoshida A, Chitnis N, Altman BJ, Tameire F, Oran A, Gennaro V, Armeson KE, McMahon SB, Wertheim GB, Dang CV, Ruggero D, Koumenis C, Fuchs SY, Diehl JA. A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival. Nature Cell Biology. PMID 29230015 DOI: 10.1038/S41556-017-0006-Y  0.381
2017 Velalopoulou A, Chatterjee S, Pietrofesa RA, Koziol-White C, Panettieri RA, Lin L, Tuttle S, Berman A, Koumenis C, Christofidou-Solomidou M. Synthetic Secoisolariciresinol Diglucoside (LGM2605) Protects Human Lung in an Ex Vivo Model of Proton Radiation Damage. International Journal of Molecular Sciences. 18. PMID 29186841 DOI: 10.3390/Ijms18122525  0.318
2017 Brady LK, Wang H, Radens CM, Bi Y, Radovich M, Maity A, Ivan C, Ivan M, Barash Y, Koumenis C. Transcriptome analysis of hypoxic cancer cells uncovers intron retention in EIF2B5 as a mechanism to inhibit translation. Plos Biology. 15: e2002623. PMID 28961236 DOI: 10.1371/Journal.Pbio.2002623  0.433
2017 Katlinski KV, Gui J, Katlinskaya YV, Ortiz A, Chakraborty R, Bhattacharya S, Carbone CJ, Beiting DP, Girondo MA, Peck AR, Puré E, Chatterji P, Rustgi AK, Diehl JA, Koumenis C, et al. Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment. Cancer Cell. 31: 194-207. PMID 28196594 DOI: 10.1016/J.Ccell.2017.01.004  0.382
2017 Bi Y, Verginadis I, Dey S, Guo l, Lin L, Zheng Y, Koumenis C. Abstract 5863: Identifying the radiosensitizing effects of PARP inhibitor in ovarian cancer Cancer Research. 77: 5863-5863. DOI: 10.1158/1538-7445.Am2017-5863  0.422
2017 Verginadis I, Encarnación J, Dey S, Koumenis C. Abstract 4500: Inhibition of PERK by small molecule inhibitors enhances the response to ionizing radiation in vitro and animal tumor models Cancer Research. 77: 4500-4500. DOI: 10.1158/1538-7445.Am2017-4500  0.374
2017 Brady LK, Wang H, Radens C, Radovich M, Maity A, Ivan C, Ivan M, Barash Y, Koumenis C. Abstract 1998: Transcriptome analysis of hypoxic head and neck cancer cells uncovers intron retention in EIF2B5 as a mechanism to reduce protein synthesis Cancer Research. 77: 1998-1998. DOI: 10.1158/1538-7445.Am2017-1998  0.354
2017 Leli NM, Dey S, Brady L, Koumenis C. Abstract 1247: Identifying novel regulators of the Unfolded Protein Response (UPR) by genome-scale CRISPR-Cas9 knockout screens Cancer Research. 77: 1247-1247. DOI: 10.1158/1538-7445.Am2017-1247  0.487
2016 Verginadis II, Kanade R, Bell B, Koduri S, Ben-Josef E, Koumenis C. A novel mouse model to study image-guided, radiation-induced intestinal injury and preclinical screening of radioprotectors. Cancer Research. PMID 28011621 DOI: 10.1158/0008-5472.Can-16-2724  0.313
2016 Brady LK, Popov V, Koumenis C. In Vivo Interrogation of the Hypoxic Transcriptome of Solid Tumors: Optimizing Hypoxic Probe Labeling with Laser Capture Microdissection for Isolation of High-Quality RNA for Deep Sequencing Analysis. Advances in Experimental Medicine and Biology. 899: 41-58. PMID 27325261 DOI: 10.1007/978-3-319-26666-4_4  0.336
2016 Pietrofesa RA, Velalopoulou A, Lehman SL, Arguiri E, Solomides P, Koch CJ, Mishra OP, Koumenis C, Goodwin TJ, Christofidou-Solomidou M. Novel Double-Hit Model of Radiation and Hyperoxia-Induced Oxidative Cell Damage Relevant to Space Travel. International Journal of Molecular Sciences. 17. PMID 27322243 DOI: 10.3390/Ijms17060953  0.366
2016 Shah S, Carriveau WJ, Li J, Campbell SL, Kopinski PK, Lim HW, Daurio N, Trefely S, Won KJ, Wallace DC, Koumenis C, Mancuso A, Wellen KE. Targeting ACLY sensitizes castration-resistant prostate cancer cells to AR antagonism by impinging on an ACLY-AMPK-AR feedback mechanism. Oncotarget. PMID 27248322 DOI: 10.18632/Oncotarget.9666  0.35
2016 Katlinskaya YV, Katlinski KV, Yu Q, Ortiz A, Beiting DP, Brice A, Davar D, Sanders C, Kirkwood JM, Rui H, Xu X, Koumenis C, Diehl JA, Fuchs SY. Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression. Cell Reports. PMID 27052162 DOI: 10.1016/J.Celrep.2016.03.006  0.394
2016 Huang M, Liu T, Ma P, Mitteer RA, Zhang Z, Kim HJ, Yeo E, Zhang D, Cai P, Li C, Zhang L, Zhao B, Roccograndi L, O'Rourke DM, Dahmane N, ... ... Koumenis C, et al. c-Met-mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma. The Journal of Clinical Investigation. PMID 27043280 DOI: 10.1172/Jci84876  0.368
2016 Daurio NA, Tuttle SW, Worth AJ, Song EY, Davis JM, Snyder NW, Blair IA, Koumenis C. AMPK activation and metabolic reprogramming by tamoxifen through estrogen receptor-independent mechanisms suggests new uses for this therapeutic modality in cancer treatment. Cancer Research. PMID 27020861 DOI: 10.1158/0008-5472.Can-15-2197  0.409
2016 Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, ... ... Koumenis C, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12: 1-222. PMID 26799652 DOI: 10.1080/15548627.2015.1100356  0.326
2016 Brady LK, Shekher R, Popov V, Ivan M, Radovich M, Koumenis C. Abstract 733: Analysis of the hypoxic transcriptome in cells and solid tumors reveals a novel spliced isoform of the key regulator of mRNA translation, eIF2B5 Cancer Research. 76: 733-733. DOI: 10.1158/1538-7445.Am2016-733  0.445
2016 Tameire F, Monroy MA, Koumenis C. Abstract 230: The role of integrated stress response (ISR) transcription factor ATF4 in metabolic adaptation of tumors to c-Myc activation Cancer Research. 76: 230-230. DOI: 10.1158/1538-7445.Am2016-230  0.455
2016 Verginadis I, Kanade R, Ben-Josef E, Koumenis C. Abstract 1662: Development of a novel mouse model to study image-guided radiation-induced gastrointestinal injury and its application in pre-clinical research Cancer Research. 76: 1662-1662. DOI: 10.1158/1538-7445.Am2016-1662  0.353
2015 Yu Q, Zhao B, Gui J, Katlinski KV, Brice A, Gao Y, Li C, Kushner JA, Koumenis C, Diehl JA, Fuchs SY. Type I interferons mediate pancreatic toxicities of PERK inhibition. Proceedings of the National Academy of Sciences of the United States of America. PMID 26627716 DOI: 10.1073/Pnas.1516362112  0.321
2015 Ye J, Palm W, Peng M, King B, Lindsten T, Li MO, Koumenis C, Thompson CB. GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2. Genes & Development. PMID 26543160 DOI: 10.1101/Gad.269324.115  0.362
2015 Lehman SL, Ryeom S, Koumenis C. Signaling through alternative Integrated Stress Response pathways compensates for GCN2 loss in a mouse model of soft tissue sarcoma. Scientific Reports. 5: 11781. PMID 26123823 DOI: 10.1038/Srep11781  0.441
2015 Lehman SL, Cerniglia GJ, Johannes GJ, Ye J, Ryeom S, Koumenis C. Translational Upregulation of an Individual p21Cip1 Transcript Variant by GCN2 Regulates Cell Proliferation and Survival under Nutrient Stress. Plos Genetics. 11: e1005212. PMID 26102367 DOI: 10.1371/Journal.Pgen.1005212  0.389
2015 Dey S, Sayers CM, Verginadis II, Lehman SL, Cheng Y, Cerniglia GJ, Tuttle SW, Feldman MD, Zhang PJ, Fuchs SY, Diehl JA, Koumenis C. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis. The Journal of Clinical Investigation. 125: 2592-608. PMID 26011642 DOI: 10.1172/Jci78031  0.455
2015 Cerniglia GJ, Dey S, Gallagher-Colombo SM, Daurio NA, Tuttle S, Busch TM, Lin A, Sun R, Esipova TV, Vinogradov SA, Denko N, Koumenis C, Maity A. The PI3K/Akt Pathway Regulates Oxygen Metabolism via Pyruvate Dehydrogenase (PDH)-E1α Phosphorylation. Molecular Cancer Therapeutics. 14: 1928-38. PMID 25995437 DOI: 10.1158/1535-7163.Mct-14-0888  0.426
2015 Tameire F, Verginadis II, Koumenis C. Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapy. Seminars in Cancer Biology. 33: 3-15. PMID 25920797 DOI: 10.1016/J.Semcancer.2015.04.002  0.411
2015 Cerniglia G, Dey S, Gallagher-Colombo SM, Daurio N, Tuttle S, Busch TM, Lin A, Esipova TV, Vinogradov S, Koumenis C, Maity A. Abstract B05: PI3K/mTOR pathway-dependent regulation of oxygen metabolism via pyruvate dehydrogenase (PDH)-E1alpha phosphorylation Molecular Cancer Therapeutics. 14. DOI: 10.1158/1538-8514.Pi3K14-B05  0.434
2015 Daurio NA, Tuttle S, Koumenis C. Abstract 5510: Tamoxifen induces estrogen receptor-independent bioenergetic stress: A synthetic lethality approach to target tumor metabolism Cancer Research. 75: 5510-5510. DOI: 10.1158/1538-7445.Am2015-5510  0.412
2015 Brady L, Popov V, Ivan M, Radovich M, Koumenis C. Abstract 3005: Investigating the impact of hypoxia-induced changes in splicing on tumor microenvironment Cancer Research. 75: 3005-3005. DOI: 10.1158/1538-7445.Am2015-3005  0.447
2015 Dey S, Sayers CM, Lehman SL, Cheng Y, Cerniglia GJ, Tuttle SW, Feldman MD, Zhang PJL, Fuchs SY, Diehl JA, Koumenis C. Abstract 1262: The transcription factor ATF4 regulates resistance to anoikis and promotes metastasis in fibrosarcoma via cooperative upregulation of Heme Oxygenase-1 with Nrf2 Cancer Research. 75: 1262-1262. DOI: 10.1158/1538-7445.Am2015-1262  0.471
2015 Cerniglia GJ, Day S, Gallagher-Colombo SM, Daurio N, Tuttle S, Busch TM, Lin A, Esipova TV, Vinogradov SA, Koumenis C, Maity A. Abstract 1140: PI3K/Akt inhibition decreases oxygen consumption In tumor cells by phosphorylating and inactivating pyruvate dehydrogenase PDH E1α subunit Cancer Research. 75: 1140-1140. DOI: 10.1158/1538-7445.Am2015-1140  0.437
2014 Koumenis C, Hammond E, Giaccia A. Tumor microenvironment and cellular stress: signaling, metabolism, imaging, and therapeutic targets. Preface. Advances in Experimental Medicine and Biology. 772: v-viii. PMID 24765667 DOI: 10.1007/978-1-4614-5915-6  0.428
2014 Ma XH, Piao SF, Dey S, McAfee Q, Karakousis G, Villanueva J, Hart LS, Levi S, Hu J, Zhang G, Lazova R, Klump V, Pawelek JM, Xu X, Xu W, ... ... Koumenis C, et al. Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma. The Journal of Clinical Investigation. 124: 1406-17. PMID 24569374 DOI: 10.1172/Jci70454  0.426
2014 Lehman SL, Ye J, Koumenis C. Abstract 487: The Integrated Stress Response kinase GCN2 regulates cell proliferation and survival through combined transcriptional and translational control of p21 (Cip1/Waf1) Cancer Research. 74: 487-487. DOI: 10.1158/1538-7445.Am2014-487  0.462
2013 Guttmann DM, Hart L, Du K, Seletsky A, Koumenis C. Inhibition of Hsp27 radiosensitizes head-and-neck cancer by modulating deoxyribonucleic acid repair. International Journal of Radiation Oncology, Biology, Physics. 87: 168-75. PMID 23849696 DOI: 10.1016/J.Ijrobp.2013.05.028  0.323
2013 Dey S, Tameire F, Koumenis C. PERK-ing up autophagy during MYC-induced tumorigenesis. Autophagy. 9: 612-4. PMID 23328692 DOI: 10.4161/Auto.23486  0.479
2013 Sayers CM, Papandreou I, Guttmann DM, Maas NL, Diehl JA, Witze ES, Koong AC, Koumenis C. Identification and characterization of a potent activator of p53-independent cellular senescence via a small-molecule screen for modifiers of the integrated stress response. Molecular Pharmacology. 83: 594-604. PMID 23229510 DOI: 10.1124/Mol.112.081810  0.457
2013 Koumenis C, Hart LS, Cunningham T, Dey S, Tameire F, Mills I, Ruggero D, Diehl AJ, Fuchs S. Abstract SY32-04: The translation initiation factor elF2α regulates cytoprotective autophagy in Myc-dependent lymphoma. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Sy32-04  0.524
2013 Lehman SL, Ye J, Koumenis C. Abstract 570: The integrated stress response kinase GCN2 regulates cell survival through p21/WAF1/CIP1 in response to nutrient deprivation. Cancer Research. 73: 570-570. DOI: 10.1158/1538-7445.Am2013-570  0.457
2013 Daurio N, Tuttle S, Sood N, Hammer D, Koumenis C. Abstract 4527: Sensitization of cancer cells to cisplatin by curcumin: mlecular mechanism and drug delivery. Cancer Research. 73: 4527-4527. DOI: 10.1158/1538-7445.Am2013-4527  0.372
2013 Dey S, Sayers CM, Koumenis C. Abstract 2934: Activation of the Integrated Stress Response target ATF4 provides resistance towards anoikis- mediated cell death and promotes metastasis. Cancer Research. 73: 2934-2934. DOI: 10.1158/1538-7445.Am2013-2934  0.498
2013 Tameire F, Hart LS, Qiu B, Koumenis C. Abstract 1689: The cytoprotective role of the UPR during c-Myc dependent transformation and tumor progression. Cancer Research. 73: 1689-1689. DOI: 10.1158/1538-7445.Am2013-1689  0.442
2013 Cerniglia GJ, Daurio N, Gallagher-Colombo SM, Busch TM, Tuttle SW, Koch CJ, Lin A, Koumenis C, Maity A. Abstract 1037: Agents that target the PI3K/mTOR pathway decrease oxygen consumption, reduce tumor hypoxia and improve radiation response in solid tumors. Cancer Research. 73: 1037-1037. DOI: 10.1158/1538-7445.Am2013-1037  0.425
2012 Hart LS, Cunningham JT, Datta T, Dey S, Tameire F, Lehman SL, Qiu B, Zhang H, Cerniglia G, Bi M, Li Y, Gao Y, Liu H, Li C, Maity A, ... ... Koumenis C, et al. ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growth. The Journal of Clinical Investigation. 122: 4621-34. PMID 23143306 DOI: 10.1172/Jci62973  0.452
2012 Chitnis NS, Pytel D, Bobrovnikova-Marjon E, Pant D, Zheng H, Maas NL, Frederick B, Kushner JA, Chodosh LA, Koumenis C, Fuchs SY, Diehl JA. miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner. Molecular Cell. 48: 353-64. PMID 23022383 DOI: 10.1016/J.Molcel.2012.08.025  0.308
2012 Cerniglia GJ, Karar J, Tyagi S, Christofidou-Solomidou M, Rengan R, Koumenis C, Maity A. Inhibition of autophagy as a strategy to augment radiosensitization by the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235. Molecular Pharmacology. 82: 1230-40. PMID 22989521 DOI: 10.1124/Mol.112.080408  0.427
2012 Karar J, Cerniglia GJ, Lindsten T, Koumenis C, Maity A. Dual PI3K/mTOR inhibitor NVP-BEZ235 suppresses hypoxia-inducible factor (HIF)-1α expression by blocking protein translation and increases cell death under hypoxia. Cancer Biology & Therapy. 13: 1102-11. PMID 22895065 DOI: 10.4161/Cbt.21144  0.449
2012 Tuttle S, Hertan L, Daurio N, Porter S, Kaushick C, Li D, Myamoto S, Lin A, O'Malley BW, Koumenis C. The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model. Cancer Biology & Therapy. 13: 575-84. PMID 22441776 DOI: 10.4161/Cbt.19772  0.33
2012 Tang X, Lucas JE, Chen JL, LaMonte G, Wu J, Wang MC, Koumenis C, Chi JT. Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs. Cancer Research. 72: 491-502. PMID 22135092 DOI: 10.1158/0008-5472.Can-11-2076  0.457
2012 Sayers CM, Koong AC, Koumenis C. Abstract 4994: An integrated stress response activator causes cellular senescence and inhibits growth in multiple tumor cell types Cancer Research. 72: 4994-4994. DOI: 10.1158/1538-7445.Am2012-4994  0.466
2012 Cerniglia GJ, Karar J, Koumenis C, Maity A. Abstract 2804: Radiosensitization by the Dual PI3K/mTOR inhibitor NVP-BEZ235 Cancer Research. 72: 2804-2804. DOI: 10.1158/1538-7445.Am2012-2804  0.416
2012 Karar J, Cerniglia GJ, Koumenis C, Maity A. Abstract 2800: Dual PI3K/mTOR inhibitor NVP BEZ-235 suppresses translation of hypoxia-inducible factor (HIF)-1α and increases cell death under hypoxia Cancer Research. 72: 2800-2800. DOI: 10.1158/1538-7445.Am2012-2800  0.441
2012 Maity A, Cerniglia GJ, Karar J, Koumenis C. Inhibition of Autophagy as a Strategy to Augment Radiosensitization by the Dual PI3K/mTOR Inhibitor NVP-BEZ235 International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.130  0.315
2011 Guttmann DM, Koumenis C. The heat shock proteins as targets for radiosensitization and chemosensitization in cancer. Cancer Biology & Therapy. 12: 1023-31. PMID 22236878 DOI: 10.4161/Cbt.12.12.18374  0.377
2011 Stewart RD, Yu VK, Georgakilas AG, Koumenis C, Park JH, Carlson DJ. Effects of radiation quality and oxygen on clustered DNA lesions and cell death. Radiation Research. 176: 587-602. PMID 21823972 DOI: 10.1667/Rr2663.1  0.316
2011 Hart LS, Dolloff NG, Dicker DT, Koumenis C, Christensen JG, Grimberg A, El-Deiry WS. Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab. Cell Cycle (Georgetown, Tex.). 10: 2331-8. PMID 21720213 DOI: 10.4161/Cc.10.14.16418  0.373
2011 Tian X, Ye J, Alonso-Basanta M, Hahn SM, Koumenis C, Dorsey JF. Modulation of CCAAT/enhancer binding protein homologous protein (CHOP)-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). The Journal of Biological Chemistry. 286: 29408-16. PMID 21697087 DOI: 10.1074/Jbc.M110.197665  0.439
2011 Bhattacharya S, Qian J, Tzimas C, Baker DP, Koumenis C, Diehl JA, Fuchs SY. Role of p38 protein kinase in the ligand-independent ubiquitination and down-regulation of the IFNAR1 chain of type I interferon receptor. The Journal of Biological Chemistry. 286: 22069-76. PMID 21540188 DOI: 10.1074/Jbc.M111.238766  0.375
2011 Marotta D, Karar J, Jenkins WT, Kumanova M, Jenkins KW, Tobias JW, Baldwin D, Hatzigeorgiou A, Alexiou P, Evans SM, Alarcon R, Maity A, Koch C, Koumenis C. In vivo profiling of hypoxic gene expression in gliomas using the hypoxia marker EF5 and laser-capture microdissection. Cancer Research. 71: 779-89. PMID 21266355 DOI: 10.1158/0008-5472.Can-10-3061  0.422
2011 Koumenis C, Zhang H, Bi M, Lehman SL, Datta T, Liu H, Thomas-Tikhonenko A, Koong A, Fuchs SY, Diehl JA, Ruggero D. Abstract SY06-02: Activation of the UPR by c-Myc promotes transformation and tumorigenesis via cytoprotective autophagy Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Sy06-02  0.483
2011 Karar J, Marotta D, Jenkins WT, Kumanova M, Jenkins K, Tobias JW, Baldwin D, Hatzigeorgiou A, Alexiou P, Evans SM, Alarcon R, Koch C, Maity A, Koumenis C. Abstract 5004:In vivoprofiling of hypoxic mRNA and miRNA expression in gliomas and head and neck tumors Cancer Research. 71: 5004-5004. DOI: 10.1158/1538-7445.Am2011-5004  0.384
2011 Welliver MX, Hart LS, Ye J, Lu C, Mick R, Kong M, Ditsworth D, Mesina A, Zhao F, Guerriero JL, Zong W, Koumenis C, Thompson CB. Abstract 2513: Molecular dissection of cell death mechanisms following ionizing radiationin vitroandin vivo Cancer Research. 71: 2513-2513. DOI: 10.1158/1538-7445.Am2011-2513  0.459
2011 Hart LS, Cunningham T, Datta T, Liu H, Koong AC, Fuchs S, Diehl JA, Ruggero D, Koumenis C. Abstract 2078: PERK-mediated autophagy promotes Myc-induced transformation and tumorigenesis Cancer Research. 71: 2078-2078. DOI: 10.1158/1538-7445.Am2011-2078  0.471
2011 Lehman SL, Sayers CM, Ye J, Hart LS, Ayeni DO, Koong A, Koumenis C. Abstract 2072: The role of the integrated stress response proteins GCN2 and ATF4 in autophagy and tumor migration Cancer Research. 71: 2072-2072. DOI: 10.1158/1538-7445.Am2011-2072  0.451
2010 Maity A, Koumenis C. Location, location, location-makes all the difference for hypoxia in lung tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4685-7. PMID 20858842 DOI: 10.1158/1078-0432.Ccr-10-2004  0.361
2010 Ye J, Kumanova M, Hart LS, Sloane K, Zhang H, De Panis DN, Bobrovnikova-Marjon E, Diehl JA, Ron D, Koumenis C. The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation. The Embo Journal. 29: 2082-96. PMID 20473272 DOI: 10.1038/Emboj.2010.81  0.419
2010 Bobrovnikova-Marjon E, Grigoriadou C, Pytel D, Zhang F, Ye J, Koumenis C, Cavener D, Diehl JA. PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage. Oncogene. 29: 3881-95. PMID 20453876 DOI: 10.1038/Onc.2010.153  0.468
2010 Lee JC, Kinniry PA, Arguiri E, Serota M, Kanterakis S, Chatterjee S, Solomides CC, Javvadi P, Koumenis C, Cengel KA, Christofidou-Solomidou M. Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiation Research. 173: 590-601. PMID 20426658 DOI: 10.1667/Rr1522.1  0.328
2010 Lehman S, Koumenis C. The role of autophagy as a mechanism of cytotoxicity by the clinically used agent MDA-7/IL-24. Cancer Biology & Therapy. 9: 537-8. PMID 20234182 DOI: 10.4161/Cbt.9.7.11381  0.338
2010 Javvadi P, Hertan L, Kosoff R, Datta T, Kolev J, Mick R, Tuttle SW, Koumenis C. Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells. Cancer Research. 70: 1941-50. PMID 20160040 DOI: 10.1158/0008-5472.Can-09-3025  0.453
2010 Bhattacharya S, HuangFu WC, Liu J, Veeranki S, Baker DP, Koumenis C, Diehl JA, Fuchs SY. Inducible priming phosphorylation promotes ligand-independent degradation of the IFNAR1 chain of type I interferon receptor. The Journal of Biological Chemistry. 285: 2318-25. PMID 19948722 DOI: 10.1074/Jbc.M109.071498  0.328
2009 Ye J, Koumenis C. ATF4, an ER stress and hypoxia-inducible transcription factor and its potential role in hypoxia tolerance and tumorigenesis. Current Molecular Medicine. 9: 411-6. PMID 19519398 DOI: 10.2174/156652409788167096  0.462
2009 Hertan LM, Koumenis C. Piling up the JNK: drug synergy through ER stress. Cancer Biology & Therapy. 8: 820-2. PMID 19458484 DOI: 10.4161/Cbt.8.9.8403  0.332
2008 Little JL, Wheeler FB, Koumenis C, Kridel SJ. Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death. Molecular Cancer Therapeutics. 7: 3816-24. PMID 19074856 DOI: 10.1158/1535-7163.Mct-08-0558  0.447
2008 Fels DR, Ye J, Segan AT, Kridel SJ, Spiotto M, Olson M, Koong AC, Koumenis C. Preferential cytotoxicity of bortezomib toward hypoxic tumor cells via overactivation of endoplasmic reticulum stress pathways. Cancer Research. 68: 9323-30. PMID 19010906 DOI: 10.1158/0008-5472.Can-08-2873  0.491
2008 Park MA, Yacoub A, Sarkar D, Emdad L, Rahmani M, Spiegel S, Koumenis C, Graf M, Curiel DT, Grant S, Fisher PB, Dent P. PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cells. Autophagy. 4: 513-5. PMID 18299661 DOI: 10.4161/Auto.5725  0.462
2008 Javvadi P, Segan AT, Tuttle SW, Koumenis C. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway. Molecular Pharmacology. 73: 1491-501. PMID 18252805 DOI: 10.1124/Mol.107.043554  0.436
2008 Park MA, Curiel DT, Koumenis C, Graf M, Chen CS, Fisher PB, Grant S, Dent P. PERK-dependent regulation of HSP70 expression and the regulation of autophagy. Autophagy. 4: 364-7. PMID 18216498 DOI: 10.4161/Auto.5593  0.39
2008 Schwartz GG, Eads D, Naczki C, Northrup S, Chen T, Koumenis C. 19-nor-1α,25-dihydroxyvitamin D2 (Paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo Cancer Biology and Therapy. 7: 430-436. PMID 18094617 DOI: 10.4161/Cbt.7.3.5418  0.403
2007 Koumenis C, Bi M, Ye J, Feldman D, Koong AC. Hypoxia and the Unfolded Protein Response Methods in Enzymology. 435: 275-293. PMID 17998059 DOI: 10.1016/S0076-6879(07)35014-3  0.374
2007 Lally BE, Geiger GA, Kridel S, Arcury-Quandt AE, Robbins ME, Kock ND, Wheeler K, Peddi P, Georgakilas A, Kao GD, Koumenis C. Identification and biological evaluation of a novel and potent small molecule radiation sensitizer via an unbiased screen of a chemical library. Cancer Research. 67: 8791-9. PMID 17875720 DOI: 10.1158/0008-5472.Can-07-0477  0.423
2007 Little JL, Wheeler FB, Fels DR, Koumenis C, Kridel SJ. Inhibition of fatty acid synthase induces endoplasmic reticulum stress in tumor cells. Cancer Research. 67: 1262-9. PMID 17283163 DOI: 10.1158/0008-5472.Can-06-1794  0.479
2007 Hart LS, Ornelles D, Koumenis C. The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage. The Journal of Biological Chemistry. 282: 6061-7. PMID 17172468 DOI: 10.1074/Jbc.M610405200  0.397
2006 Fels DR, Koumenis C. The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biology & Therapy. 5: 723-8. PMID 16861899 DOI: 10.4161/Cbt.5.7.2967  0.477
2006 Koumenis C, Wouters BG. "Translating" tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways. Molecular Cancer Research : McR. 4: 423-36. PMID 16849518 DOI: 10.1158/1541-7786.Mcr-06-0150  0.479
2006 Koumenis C, Maxwell PH. Low oxygen stimulates the intellect. Symposium on hypoxia and development, physiology and disease. Embo Reports. 7: 679-84. PMID 16799463 DOI: 10.1038/Sj.Embor.7400733  0.349
2006 Monjazeb AM, High KP, Connoy A, Hart LS, Koumenis C, Chilton FH. Arachidonic acid-induced gene expression in colon cancer cells. Carcinogenesis. 27: 1950-60. PMID 16704987 DOI: 10.1093/Carcin/Bgl023  0.427
2006 Koumenis C. ER stress, hypoxia tolerance and tumor progression. Current Molecular Medicine. 6: 55-69. PMID 16472113 DOI: 10.2174/156652406775574604  0.489
2006 Koritzinsky M, Magagnin MG, van den Beucken T, Seigneuric R, Savelkouls K, Dostie J, Pyronnet S, Kaufman RJ, Weppler SA, Voncken JW, Lambin P, Koumenis C, Sonenberg N, Wouters BG. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. The Embo Journal. 25: 1114-25. PMID 16467844 DOI: 10.1038/Sj.Emboj.7600998  0.377
2005 Monjazeb AM, High KP, Koumenis C, Chilton FH. Inhibitors of arachidonic acid metabolism act synergistically to signal apoptosis in neoplastic cells. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 73: 463-74. PMID 16169197 DOI: 10.1016/J.Plefa.2005.07.009  0.419
2005 Bi M, Naczki C, Koritzinsky M, Fels D, Blais J, Hu N, Harding H, Novoa I, Varia M, Raleigh J, Scheuner D, Kaufman RJ, Bell J, Ron D, Wouters BG, ... Koumenis C, et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. The Embo Journal. 24: 3470-81. PMID 16148948 DOI: 10.1038/Sj.Emboj.7600777  0.475
2005 Wouters BG, van den Beucken T, Magagnin MG, Koritzinsky M, Fels D, Koumenis C. Control of the hypoxic response through regulation of mRNA translation. Seminars in Cell & Developmental Biology. 16: 487-501. PMID 15896987 DOI: 10.1016/J.Semcdb.2005.03.009  0.457
2005 Hart LS, Yannone SM, Naczki C, Orlando JS, Waters SB, Akman SA, Chen DJ, Ornelles D, Koumenis C. The adenovirus E4orf6 protein inhibits DNA double strand break repair and radiosensitizes human tumor cells in an E1B-55K-independent manner. The Journal of Biological Chemistry. 280: 1474-81. PMID 15507430 DOI: 10.1074/Jbc.M409934200  0.378
2004 Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP, Wang L, Burnstein KL, Holick MF, Koumenis C. Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3. Carcinogenesis. 25: 1015-26. PMID 14742320 DOI: 10.1093/Carcin/Bgh086  0.335
2002 Koumenis C, Naczki C, Koritzinsky M, Rastani S, Diehl A, Sonenberg N, Koromilas A, Wouters BG. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Molecular and Cellular Biology. 22: 7405-16. PMID 12370288 DOI: 10.1128/Mcb.22.21.7405-7416.2002  0.442
2002 Parks GD, Young VA, Koumenis C, Wansley EK, Layer JL, Cooke KM. Controlled cell killing by a recombinant nonsegmented negative-strand RNA virus. Virology. 293: 192-203. PMID 11853412 DOI: 10.1006/Viro.2001.1298  0.338
2001 Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M, Giaccia A. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Molecular and Cellular Biology. 21: 1297-310. PMID 11158315 DOI: 10.1128/Mcb.21.4.1297-1310.2001  0.382
1998 Giaccia AJ, Brown JM, Wouters B, Denko N, Koumenis C. Cancer therapy and tumor physiology. Science (New York, N.Y.). 279: 12-3. PMID 9441397 DOI: 10.1126/Science.279.5347.10E  0.429
1998 Marquez SD, Derr J, Koumenis C, Giaccia AJ. Bax protein is not involved in hypoxia-induced apoptosis International Journal of Radiation Oncology*Biology*Physics. 42: 136. DOI: 10.1016/S0360-3016(98)80125-9  0.342
1997 Koumenis C, Giaccia A. Transformed cells require continuous activity of RNA polymerase II to resist oncogene-induced apoptosis. Molecular and Cellular Biology. 17: 7306-16. PMID 9372962 DOI: 10.1128/Mcb.17.12.7306  0.402
1996 Fried LM, Koumenis C, Peterson SR, Green SL, van Zijl P, Allalunis-Turner J, Chen DJ, Fishel R, Giaccia AJ, Brown JM, Kirchgessner CU. The DNA damage response in DNA-dependent protein kinase-deficient SCID mouse cells: replication protein A hyperphosphorylation and p53 induction. Proceedings of the National Academy of Sciences of the United States of America. 93: 13825-30. PMID 8943020 DOI: 10.1073/Pnas.93.24.13825  0.318
1992 Koumenis C, Eskin A. The hunt for mechanisms of circadian timing in the eye of Aplysia. Chronobiology International. 9: 201-21. PMID 1611674 DOI: 10.3109/07420529209064530  0.324
Show low-probability matches.